Value-Based Care Gets Real

The mandatory CMS TEAM program begins next year. Are you ready? As hospitals consider their options for addressing the mandate, here are some actions to consider. The post Value-Based Care Gets Real appeared first on MedCity News.

Read More

Overlooked in the Overdose Crisis: Addressing Substance Use Treatment for Asian American, Native Hawaiian, and Pacific Islander Communities

Researchers and policymakers must challenge the default framing and stereotypical minority myth mindset which uniformly classifies AANHPI communities as low-risk, hindering both visibility and resource allocation.  The post Overlooked in the Overdose Crisis: Addressing Substance Use Treatment for Asian American, Native Hawaiian, and Pacific Islander Communities appeared first on MedCity News.

Read More

Novartis Gets Phase 3-Ready Rare Kidney Disease Drug via $800M Regulus Acquisition

Regulus Therapeutics drug farabursen is a potential first-in-class treatment for a rare kidney disease whose only FDA-approved therapy introduces severe toxicity risks. Farabursen is joining a Novartis drug lineup spanning several therapies for rare renal disorders. The post Novartis Gets Phase 3-Ready Rare Kidney Disease Drug via $800M Regulus Acquisition appeared first on MedCity News.

Read More